Latest From Biotech Now

Small Business Innovators Talk about Their Emerging Biotech

medical_research

Last June, for the first time, the BIO International Convention hosted a special section on the convention floor for early stage startups and small companies to share their biotech innovations. About 50 companies in all made up this Innovation Zone, a space jointly created by BIO, the National Science Foundation (NSF), and the National Institutes of Health (NIH), and foot traffic was heavy. Attendees got first-person accounts of some of the most inventive, potentially transformative Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Labeling Initiatives Fall in 2014 Elections; Maui Farmers Brace for Legal Fight

food label

The ag, biotech and food communities watched closely as the results of ballot initiatives in Colorado (Proposition 105) and Oregon (Measure 92) unfolded in the wake of the November 4 elections. Like previous ballet initiatives in California in 2012 and Washington State in 2013, the Colorado and Oregon proposals would have required the mandatory labeling of foods containing biotech ingredients. Voters in both Colorado and Oregon voted against the labeling initiatives, with the Colorado measure Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

The Term GMO Has Multiple Facets

admin-ajax (1)

PRI (Public Radio International)‘s Innovation Hub published a recent blog discussing why the term GMO has become ‘scientifically meaningless’. The story was first published as a blog post from PRI’s Innovation Hub with Kara Miller. The blog is interesting because it reminds us that each biotech crop should be looked at on a case-to-case basis. The term Genetically Modified Organism (GMO) can be seen as having with having multiple interpretations: The reality is that GMOs — and the discussion around them — are more nuanced than many of us assume. And that starts Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,

Charcot-Marie-Tooth Association: Success Factors Driving Industry-Patient Group Partnerships

patient-summit-4

At this year’s BIO Patient & Health Advocacy Summit, a major theme was the power of partnerships between patient advocacy groups and other stakeholders including industry, government, and academia. One patient group which has been very successful at creating and leveraging partnerships to advance the drug development process is the Charcot-Marie-Tooth Association (CMTA), a group representing patients with Charcot-Marie-Tooth (CMT) disease. CMT is the most common hereditary motor and sensory neuropathy, affecting about 150,000 patients Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

U-T San Diego Commentary: Lack of Preparedness to Ebola Is Symptom of Larger Disease

admin-ajax

Last week, the U-T San Diego published an op-ed by Betrand Liang, CEO of Pfenex Inc., a BIO member, arguing that our current lack of vaccines and therapies for Ebola is a symptom of a larger problem. That problem, Liang argues, is a lack of funding for critical biodefense programs which Congress passed in 2004 as a way to prepare us for biological agents like anthrax, smallpox, and Ebola, as well as chemical, radiological, and Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,